BioSpace News Archive

Young people around the world commonly experience anxiety and depression, but it can be hard to identify how each person can best manage their own mental health.

Rare Disease Advisory Councils enable the rare community to have a say in how their state’s programs and policies can support patients and caregivers

University of Colorado Anschutz Medical Campus, Chancellor Discovery Innovation Fund (CDI Fund) Finalizes Investment in Summit Biolabs

Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis and other diseases caused by nonsense mutations limiting production of functional proteins, is pleased to announce that Dr. Gregory Williams, Chief Executive Officer of Eloxx, will participate in a fireside chat and host one-on-one meetings with investors at the Piper Sandler 32nd Annual Virtual Growth Conference.

Nym Health, pioneers of Clinical Language Understanding (CLU) technology, today announced that Geisinger is deploying Nym’s autonomous medical coding technology to all nine of its hospital emergency departments.

As schools around the world evaluate how to reopen safely amidst the COVID-19 pandemic, the Ruidoso Municipal School District is taking important steps to provide a safer environment for students and employees as they return to in-person learning.

RedHawk Holdings Corp. (OTC: SNDD) (“RedHawk” or the “Company”), a diversified holding company primarily engaged in sales and distribution of medical devices, announced today its financial results for the three months and fiscal year ended June 30, 2020 . For the three month period ended June 30, 2020 , on revenues of $916

Melmark is pleased to announce the receipt of a $21.5 million endowment gift from the Anne and Brutus Kenan fund to further secure the not-for-profit organization’s mission well into the future. Melmark provides clinically-

Bosley is with you every step of the way: Easy, convenient and confidential, this service discretely delivers hair loss treatments right to your doorstep

Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, announced today the completion of a Type A meeting with the U.S. Food and Drug Administration (FDA) confirming a pathway for resubmission for approval of the Company’s drug candidate Libervant